ACA
Aptus Capital Advisors Portfolio holdings
AUM
$10.1B
This Quarter Return
-6.92%
1 Year Return
+13.38%
3 Year Return
+48.08%
5 Year Return
+58.01%
10 Year Return
–
AUM
$375M
AUM Growth
–
Cap. Flow
+$375M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
61.05%
Holding
170
New
161
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Aptus Defined Risk ETF
DRSK
|
$46.1M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$43.6M |
| 3 |
FTVA
Aptus Fortified Value ETF
FTVA
|
$32.6M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$23.4M |
| 5 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$18.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 5.05% |
| 2 | Technology | 4.96% |
| 3 | Consumer Discretionary | 4.87% |
| 4 | Industrials | 3.47% |
| 5 | Financials | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Louisiana-Pacific
LPX
$6.43B
| $1.58M | 0.42% |
+71,298
| New | +$1.58M |
|
27
Paychex
PAYX
$48.7B
| $1.58M | 0.42% |
+24,299
| New | +$1.58M |
|
28
Applied Materials
AMAT
$123B
| $1.58M | 0.42% |
+48,158
| New | +$1.58M |
|
29
Booking.com
BKNG
$179B
| $1.57M | 0.42% |
+914
| New | +$1.57M |
|
30
Lam Research
LRCX
$122B
| $1.57M | 0.41% |
+11,522
| New | +$1.57M |
|
31
Oracle
ORCL
$625B
| $1.57M | 0.41% |
+34,710
| New | +$1.57M |
|
32
Western Union
WU
$2.81B
| $1.55M | 0.41% |
+90,979
| New | +$1.55M |
|
33
Acuity Brands
AYI
$10.1B
| $1.52M | 0.4% |
+13,220
| New | +$1.52M |
|
34
Teradyne
TER
$18.9B
| $1.52M | 0.4% |
+48,395
| New | +$1.52M |
|
35
SiriusXM
SIRI
$7.79B
| $1.51M | 0.4% |
+265,308
| New | +$1.51M |
|
36
Biogen
BIIB
$20.8B
| $1.49M | 0.39% |
+4,943
| New | +$1.49M |
|
37
CVS Health
CVS
$92.9B
| $1.49M | 0.39% |
+22,706
| New | +$1.49M |
|
38
Accenture
ACN
$157B
| $1.48M | 0.39% |
+10,479
| New | +$1.48M |
|
39
Allison Transmission
ALSN
$7.32B
| $1.47M | 0.39% |
+33,534
| New | +$1.47M |
|
40
General Mills
GIS
$26.4B
| $1.47M | 0.39% |
+37,726
| New | +$1.47M |
|
41
Robert Half
RHI
$3.78B
| $1.46M | 0.39% |
+25,549
| New | +$1.46M |
|
42
United Therapeutics
UTHR
$17.9B
| $1.43M | 0.38% |
+13,175
| New | +$1.43M |
|
43
Manhattan Associates
MANH
$12.6B
| $1.43M | 0.38% |
+33,763
| New | +$1.43M |
|
44
LyondellBasell Industries
LYB
$17.5B
| $1.43M | 0.38% |
+17,145
| New | +$1.43M |
|
45
Snap-on
SNA
$16.7B
| $1.42M | 0.37% |
+9,755
| New | +$1.42M |
|
46
Ross Stores
ROST
$49.3B
| $1.42M | 0.37% |
+17,024
| New | +$1.42M |
|
47
MKS Inc. Common Stock
MKSI
$6.65B
| $1.4M | 0.37% |
+21,655
| New | +$1.4M |
|
|
CDK
48
DELISTED
CDK Global, Inc.
CDK
| $1.39M | 0.37% |
+28,997
| New | +$1.39M |
|
49
Gilead Sciences
GILD
$140B
| $1.37M | 0.36% |
+21,938
| New | +$1.37M |
|
50
Altria Group
MO
$112B
| $1.36M | 0.36% |
+27,545
| New | +$1.36M |
|